These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22273841)
61. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Fairchild RL; VanBuskirk AM; Kondo T; Wakely ME; Orosz CG Transplantation; 1997 Jun; 63(12):1807-12. PubMed ID: 9210509 [TBL] [Abstract][Full Text] [Related]
62. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633 [TBL] [Abstract][Full Text] [Related]
63. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811 [TBL] [Abstract][Full Text] [Related]
64. Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation. Iwasaki K; Miwa Y; Ogawa H; Yazaki S; Iwamoto M; Furusawa T; Onishi A; Kuzuya T; Haneda M; Watarai Y; Uchida K; Kobayashi T Transplantation; 2012 Feb; 93(4):390-7. PubMed ID: 22222784 [TBL] [Abstract][Full Text] [Related]
65. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951 [TBL] [Abstract][Full Text] [Related]
70. Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection. Sun Y; Feng J; Shi J; Lu X; Xie A; Chen Y; Dong N Transplantation; 2014 Jun; 97(12):1233-9. PubMed ID: 24825519 [TBL] [Abstract][Full Text] [Related]
76. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction. Stuckey LJ; Kamoun M; Chan KM Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499 [TBL] [Abstract][Full Text] [Related]
77. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671 [TBL] [Abstract][Full Text] [Related]
78. Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection. Naemi FM; Carter V; Kirby JA; Ali S Transplantation; 2013 Aug; 96(3):258-66. PubMed ID: 23823649 [TBL] [Abstract][Full Text] [Related]
80. Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats. Simeoni E; Dudler J; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G Eur J Cardiothorac Surg; 2007 Feb; 31(2):222-8. PubMed ID: 17182252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]